SCHEMBL1006439

SCHEMBL1006439

[O]CCCCCCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1004944 1.00 GPR84 (0.45)
SCHEMBL1006930 1.00 GPR84 (0.45)
SCHEMBL329265 1.00
SCHEMBL3028793 1.00 GPR84 (0.45)
SCHEMBL1007247 1.00 GPR84 (0.45)
SCHEMBL1008160 1.00 GPR84 (0.45)
SCHEMBL1007034 1.00 GPR84 (0.45)
SCHEMBL1006956 1.00 GPR84 (0.45)
SCHEMBL1007009 1.00 GPR84 (0.45)
SCHEMBL1006246 1.00 GPR84 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105611920-B Preparation of hydroxy-diphenylmethane derivatives 泰拉科斯萨普有限责任公司 2021-07-16 CN disclosed
EP-3055281-B1 PREPARATION OF HYDROXY-BENZYLBENZENE DERIVATIVES THERACOS SUB LLC (US) 2020-01-08 EP disclosed
US-10093616-B2 Preparation of hydroxy-benzylbenzene derivatives THERACOS SUB, LLC (US) 2018-10-09 US disclosed
US-9725478-B2 Process for the preparation of benzylbenzene SGLT2 inhibitors THERACOS SUB, LLC (US) 2017-08-08 US disclosed
US-20160355471-A1 PREPARATION OF HYDROXY-BENZYLBENZENE DERIVATIVES THERACOSBIO, LLC 2016-12-08 US disclosed
US-9464043-B2 Preparation of hydroxy-benzylbenzene derivatives THERACOS SUB, LLC (US) 2016-10-11 US disclosed
EP-3055281-A1 PREPARATION OF HYDROXY-BENZYLBENZENE DERIVATIVES Theracos Sub, LLC (US) 2016-08-17 EP disclosed
US-20160207952-A1 PROCESS FOR THE PREPARATION OF BENZYLBENZENE SGLT2 INHIBITORS THERACOSBIO, LLC 2016-07-21 US disclosed
US-9231278-B2 Electrolyte solution for magnesium battery and magnesium battery containing this electrolyte solution NATIONAL UNIVERSITY CORPORATION NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2016-01-05 US disclosed
US-9193751-B2 Process for the preparation of benzylbenzene SGLT2 inhibitors THERACOS, INC. (US) 2015-11-24 US disclosed
EP-0382185-B1 Carbostyril derivatives OTSUKA PHARMA CO LTD (JP) 1994-06-15 EP disclosed
WO-1994001113-A1 OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1994-01-20 WO disclosed
US-5225402-A Vasopressin antagonist, vasodilation, hypotensive, diuretics and anticoagulants OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-07-06 US disclosed
US-5219852-A Hypoglycemic agents, treatment of diabetes and obesity DR. KARL THOMAE GMBH (DE) 1993-06-15 US disclosed
US-5053548-A Containing hydroxy substituents; nervous system disorders OTSUKA PHARMACEUTICAL COMPANY, LTD. (JP) 1991-10-01 US disclosed
EP-0239815-B1 SUBSTITUTED THIAZOLES AND OXAZOLES, MEDICINES CONTAINING THESE COMPOUNDS AND PROCESS FOR THEIR PREPARATION Dr. Karl Thomae GmbH (DE) 1991-07-24 EP disclosed
US-5026702-A Enhances physical performance in animals, effective in lowering blood sugar, reducing body fat and lowering atherogenic lipoproteins DR. KARL THOMAE, GMBH (DE) 1991-06-25 US disclosed
EP-0382213-A2 Biphenyl derivative, nerve cell degeneration repairing or protecting agent and process for preparing a phenyl derivative contained in the agent OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-08-16 EP disclosed
EP-0382185-A2 Carbostyril derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-08-16 EP disclosed
US-4886814-A LOWER BLOOD SUGAR DR. KARL THOMAS GMBH (DE) 1989-12-12 US disclosed